Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,305 | 86 | 95.8% |
| Education | $99.99 | 1 | 2.9% |
| Honoraria | $25.59 | 1 | 0.7% |
| Gift | $19.40 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $429.77 | 7 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $376.09 | 7 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $321.56 | 2 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $271.17 | 9 | $0 (2024) |
| Amgen Inc. | $271.11 | 9 | $0 (2024) |
| Allergan, Inc. | $229.57 | 11 | $0 (2021) |
| RxSight Inc | $217.77 | 6 | $0 (2024) |
| Sight Sciences, Inc. | $198.45 | 3 | $0 (2021) |
| NEW WORLD MEDICAL,INC. | $153.32 | 2 | $0 (2018) |
| Glaukos Corporation | $151.07 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $604.77 | 16 | Amgen Inc. ($271.11) |
| 2023 | $554.14 | 12 | Johnson & Johnson Surgical Vision, Inc. ($149.41) |
| 2022 | $285.23 | 10 | RxSight Inc ($173.17) |
| 2021 | $454.06 | 13 | Allergan, Inc. ($154.96) |
| 2020 | $361.30 | 8 | Sight Sciences, Inc. ($183.59) |
| 2019 | $411.65 | 9 | Alcon Vision LLC ($131.51) |
| 2018 | $329.55 | 10 | Sun Pharmaceutical Industries Inc. ($130.64) |
| 2017 | $449.20 | 11 | Omeros Corporation ($130.54) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Ophthalmology | ||||||
| 12/12/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/18/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/01/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Ophthalmology | ||||||
| 08/29/2024 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Optics | ||||||
| 08/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/13/2024 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Optics | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $195.00 | General |
| 07/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: EYE CARE | ||||||
| 04/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/26/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/01/2023 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Optics | ||||||
| 11/30/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: TEPEZZA | ||||||
| 11/29/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Ophthalmology | ||||||
| 11/14/2023 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $130.05 | General |
| Category: Ophthalmology | ||||||
| 10/26/2023 | Johnson & Johnson Surgical Vision, Inc. | Tecnis IOL (Device) | Food and Beverage | In-kind items and services | $137.48 | General |
| Category: Optics | ||||||
| 09/16/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: TEPEZZA | ||||||
| 09/14/2023 | AbbVie Inc. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: EYE CARE | ||||||
| 07/19/2023 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Honoraria | In-kind items and services | $25.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/18/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device) | Food and Beverage | In-kind items and services | $126.56 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 795 | 5,051 | $393,069 | $285,500 |
| 2022 | 11 | 786 | 6,543 | $403,962 | $295,745 |
| 2021 | 10 | 989 | 6,989 | $524,454 | $382,026 |
| 2020 | 16 | 1,192 | 6,254 | $540,199 | $390,083 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 276 | 501 | $234,288 | $180,199 | 76.9% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 68 | 68 | $69,785 | $43,689 | 62.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 18 | 3,999 | $26,058 | $18,881 | 72.5% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 20 | 29 | $18,694 | $14,137 | 75.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 103 | $12,634 | $8,310 | 65.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $8,512 | $6,403 | 75.2% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 18 | 51 | $6,614 | $4,866 | 73.6% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2023 | 13 | 13 | $9,575 | $4,245 | 44.3% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 97 | 99 | $3,083 | $2,035 | 66.0% |
| 92285 | Photography of content of eyes | Office | 2023 | 116 | 119 | $2,503 | $1,846 | 73.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $1,322 | $888.55 | 67.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 288 | 506 | $240,242 | $182,132 | 75.8% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 66 | 66 | $67,058 | $42,763 | 63.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 21 | 5,485 | $33,854 | $26,187 | 77.4% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 28 | 36 | $23,567 | $18,076 | 76.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 129 | $15,780 | $10,525 | 66.7% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 21 | 64 | $8,232 | $5,562 | 67.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $5,494 | $3,818 | 69.5% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 11 | 11 | $3,152 | $2,232 | 70.8% |
| 92285 | Photography of content of eyes | Office | 2022 | 106 | 114 | $2,390 | $1,738 | 72.7% |
| 92081 | Exam of visual field with limited testing | Office | 2022 | 72 | 77 | $2,385 | $1,566 | 65.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 21 | $1,808 | $1,146 | 63.4% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 411 | 736 | $354,305 | $261,647 | 73.8% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2021 | 57 | 57 | $60,058 | $37,369 | 62.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 24 | 5,616 | $34,717 | $27,495 | 79.2% |
About Dr. Michael Chamberlain, D.O
Dr. Michael Chamberlain, D.O is a Ophthalmology healthcare provider based in Jenks, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1366757387.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Chamberlain, D.O has received a total of $3,450 in payments from pharmaceutical and medical device companies, with $604.77 received in 2024. These payments were reported across 89 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,305).
As a Medicare-enrolled provider, Chamberlain has provided services to 3,762 Medicare beneficiaries, totaling 24,837 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Jenks, OK
- Active Since 08/13/2010
- Last Updated 03/22/2019
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1366757387
Products in Payments
- TEPEZZA (Biological) $271.11
- ACTHAR (Biological) $198.85
- OMNI (Device) $183.59
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $173.17
- Ahmed Glaucoma Valve (Device) $153.32
- Tecnis IOL (Device) $137.48
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $134.99
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $130.64
- Tecnis Multifocal Family of 1-piece IOLS (Device) $130.13
- ARGOS (Device) $130.05
- AcrySof IQ PanOptix (Device) $130.01
- PROKERA (Device) $126.56
- PanOptix (Device) $125.00
- TECNIS IOL (Medical Supply) $120.06
- RESTASIS MULTIDOSE (Drug) $119.29
- TEPEZZA (Drug) $109.77
- XIIDRA (Drug) $97.40
- Cequa (Drug) $95.39
- OMIDRIA (Drug) $85.61
- LUMIGAN (Drug) $79.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.